Diabetes News and Research

Latest Diabetes News and Research

Two common operations for SUI help women achieve similar levels of dryness: Study

Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.

19 May 2010

Generex Biotechnology's Phase I study data of AE37 for prostate cancer published

Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen Express, Inc.

19 May 2010

Roche Diagnostics, ACC collaborate to develop biomarkers clinical resource Web portal

Roche Diagnostics and the American College of Cardiology have begun a unique collaboration to develop a peer-reviewed biomarkers clinical resource Web portal.

From Roche Sequencing and Life Science 19 May 2010

Roche, Biogen Idec discontinue ocrelizumab clinical development programme for RA

Roche and Biogen Idec today announced their decision to discontinue the ocrelizumab clinical development programme in patients with rheumatoid arthritis (RA).

19 May 2010

Cincinnati Children's Hospital Medical Center launches REGID

A new nationwide registry will allow researchers to conduct larger, more effective studies of often misdiagnosed disorders that affect thousands of children in the United States.

19 May 2010

30 percent risk of heart attack in Australians over 55

According to a new study researchers have warned that at least one in five Australians over the age of 55 have a 30 percent chance of suffering a potentially fatal heart attack or stroke in the next five years.

18 May 2010

Harbor BioSciences announces presentation of new data from Apoptone Phase I/IIa trial at ASCO Annual Meeting

Harbor BioSciences, Inc. today announced that new data from the Phase I/IIa clinical trial of the company's lead drug candidate Apoptone®, its anticancer drug candidate being developed for prostate cancer, will be presented as part of the Scientific Program in a General Poster Session at the American Society of Clinical Oncology (ASCO) Annual Meeting.

18 May 2010

Jonas Brothers help raise funds for Childrens Hospital Los Angeles during Rock For Diabetes event

The multi-platinum album selling and Grammy nominated music artists, Jonas Brothers, joined more than 200 guests at the home of Danny DeVito and Rhea Perlman on Sunday, May 16 during the annual "Rock For Diabetes" event, to help raise funds for the Center for Endocrinology, Diabetes and Metabolism at Childrens Hospital Los Angeles. Performing a special live show for attendees, the event raised more than $250,000 for the Center.

18 May 2010

Adults with newly diagnosed type 1 diabetes recruited for Protege Encore clinical trial

Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.

18 May 2010

Benefits of aerobic training outclass those of lower-intensity walking programs

What to do: walk around the block or work up a sweat in an aerobic workout at the gym? If you're looking for the best health benefits from an exercise program, a traditional aerobic fitness program that gets your heart pumping beats a walking program hands down. But if you want to get moving, a walking program is easier to do, it's good for you, and you're more likely to stick with it.

18 May 2010

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.

18 May 2010

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.

18 May 2010

Pfizer, Washington University announce indications discovery collaboration

In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.

18 May 2010

University of Leeds researchers identify natural defence mechanism against heart disease

A natural defence mechanism against heart disease could be switched on by steroids sold as health supplements, according to researchers at the University of Leeds.

18 May 2010

PositiveID announces early completion of iGlucose system prototype development

PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.

18 May 2010

Tests of kidney function, damage predict risk of death from cardiovascular diseases: Study

Common tests of kidney function and damage predict the risk of death from cardiovascular diseases and all causes, according to a paper from the Chronic Kidney Disease Prognosis Consortium, established last year by Kidney Disease: Improving Global Outcomes.

18 May 2010

Apnex HGNS System shows promising results in people suffering from OSA

Apnex Medical announced today that preliminary data from a first-in-man clinical study showed significant improvements in sleep for people suffering from obstructive sleep apnea. The Apnex HGNS™ System, developed by the St. Paul-based company, is a device designed to treat OSA, which is a serious life-threatening illness characterized by fragmented sleep and excessive day-time sleepiness.

18 May 2010

Population Diagnostics receives NINDS grant for identifying genetic causes of Parkinson's Disease

Population Diagnostics, Inc. ("PDx"), a private company with a novel approach to revealing the genetic causes of disease and predicting drug response, announced today it has been awarded a federal grant to identify the genetic causes of Parkinson's Disease. Funded by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health, the project is being led by Eli Hatchwell, MD, PhD, an Associate Professor at Stony Brook University Medical Center and a co-founder of PDx.

18 May 2010

Echo Therapeutics first-quarter net loss increases to $1.9 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010.

18 May 2010

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

18 May 2010

Diabetes News and Research

Latest Diabetes News and Research

Two common operations for SUI help women achieve similar levels of dryness: Study

Generex Biotechnology's Phase I study data of AE37 for prostate cancer published

Roche Diagnostics, ACC collaborate to develop biomarkers clinical resource Web portal

Roche, Biogen Idec discontinue ocrelizumab clinical development programme for RA

Cincinnati Children's Hospital Medical Center launches REGID

30 percent risk of heart attack in Australians over 55

Harbor BioSciences announces presentation of new data from Apoptone Phase I/IIa trial at ASCO Annual Meeting

Jonas Brothers help raise funds for Childrens Hospital Los Angeles during Rock For Diabetes event

Adults with newly diagnosed type 1 diabetes recruited for Protege Encore clinical trial

Benefits of aerobic training outclass those of lower-intensity walking programs

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

Pfizer, Washington University announce indications discovery collaboration

University of Leeds researchers identify natural defence mechanism against heart disease

PositiveID announces early completion of iGlucose system prototype development

Tests of kidney function, damage predict risk of death from cardiovascular diseases: Study

Apnex HGNS System shows promising results in people suffering from OSA

Population Diagnostics receives NINDS grant for identifying genetic causes of Parkinson's Disease

Echo Therapeutics first-quarter net loss increases to $1.9 million

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in